MFCD00010733
2,5-Pyrrolidinedione, 1-(((9H-fluoren-9-ylmethoxy)carbonyl)oxy)-
1-{[(9H-fluoren-9-ylmethoxy)carbonyl]oxy}pyrrolidine-2,5-dione
9-Fluorenylmethyl succinimidyl carbonate
N-(9-Fluorenylmethoxycarbonyloxy) succinimide
1-{[(9H-Fluoren-9-ylmethoxy)carbonyl]oxy}pyrrolidin-2,5-dion
2,5-dioxotetrahydro-1H-pyrrol-1-yl (9H-fluoren-9-ylmethyl) carbonate
1-{[(9H-Fluoren-9-ylmethoxy)carbonyl]oxy}-2,5-pyrrolidinedione
(2,5-dioxopyrrolidin-1-yl) 9H-fluoren-9-ylmethyl carbonate
EINECS 433-520-5
2,5-Pyrrolidinedione, 1-[[(9H-fluoren-9-ylmethoxy)carbonyl]oxy]-
Fmoc-OSu

Fluorenylmoxycarbonyl succinimide (FMOC-Succinimide) is an amino acid derivative that belongs to the family of FMOC-protected amino acids. It is widely used in the synthesis of peptides and proteins in the pharmaceutical industry.

FMOC-Succinimide is produced through the reaction of succinimide with FMOC-Cl in the presence of a base such as triethylamine. The resulting product is a white powder that is soluble in organic solvents such as DMF, DMSO, and CHCl3.

One of the main advantages of using FMOC-Succinimide as a protective group is its stability to a wide range of reaction conditions. This allows for the synthesis of peptides and proteins under harsh reaction conditions without the risk of deprotection or cleavage of the FMOC group. Additionally, FMOC-Succinimide can be easily removed using mild base treatment, which does not affect the peptide or protein backbone.

The market for FMOC-Succinimide is expected to grow in the coming years, driven by the increasing demand for peptides and proteins in the pharmaceutical industry. The rise in demand for peptide therapeutics, which have the potential to treat a wide range of diseases, is expected to be a key driver of growth. Additionally, the increasing use of peptides in drug discovery and development is expected to drive demand for FMOC-Succinimide.

In terms of regional market trends, North America and Europe are currently the largest markets for FMOC-Succinimide, owing to the presence of major pharmaceutical companies and research institutions in these regions. However, the Asia-Pacific region is expected to see the highest growth rate, driven by the growing pharmaceutical industry in countries such as China and India.

In conclusion, FMOC-Succinimide is a widely used amino acid derivative that has proven to be a valuable protective group in the synthesis of peptides and proteins. With the increasing demand for peptide therapeutics and the growing pharmaceutical industry in Asia-Pacific, the market for FMOC-Succinimide is expected to continue to grow in the coming years.